NanoString Clocks 17% Revenue Growth In Q4

NanoString Technologies Inc NSTG reported Q4 FY21 sales of $42.45 million, 17.1% Y/Y, beating analysts' average estimate of $41.5 million.

  • "We delivered a strong finish to 2021, generating more than 70 Q4 instrument orders across GeoMx and CosMx," said Brad Gray, president & CEO.
  • This year, the company plans to drive GeoMx into mainstream research, launch the CosMx spatial molecular imager, and integrate both products with a cloud-based informatics portal, he said, while continuing to grow sales of the nCounter platform.
  • Instrument revenues reached $17.6 million, +15%. Revenues from GeoMx Digital Spatial Profiler were $11.9 million, up 27%, and revenues from nCounter instrument were $5.7 million, down 5%.
  • Consumables revenues amounted to $19.9 million, up 20%, including $6.1 million from GeoMx DSP consumables, more than double Q4 2020.
  • The installed instrument base grew to 255 GeoMx DSP systems and 1,050 nCounter Analysis systems as of Dec. 31.
  • Nanostring's Q4 EPS loss was $(0.64), higher than the consensus of $(0.59).
  • The company ended 2021 with $107.1 million in cash and cash equivalents and $241.8 million in short-term investments.
  • Guidance: NanoString expects FY22 total product and service revenue of $170 million - $180 million, representing a Y/Y growth of 18% - 25%.
  • It expects revenues from GeoMx DSP of about $73 million - $78 million, up 41% - 50%, and revenues from nCounter of $97 million - $102 million, up 5% - 11%.
  • Price Action: NSTG shares closed higher at 0.23% at $35.54 on Tuesday.
Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Posted In: EarningsNewsGuidanceHealth CareSmall CapGeneralBriefs
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!